HEMOGENYX PHARMPLC (Germany) Performance
| 5HU Stock | EUR 3.98 0.08 2.05% |
The company retains a Market Volatility (i.e., Beta) of 0.15, which attests to not very significant fluctuations relative to the market. As returns on the market increase, HEMOGENYX PHARMPLC's returns are expected to increase less than the market. However, during the bear market, the loss of holding HEMOGENYX PHARMPLC is expected to be smaller as well. At this point, HEMOGENYX PHARMPLC has a negative expected return of -0.45%. Please make sure to check out HEMOGENYX PHARMPLC's downside deviation, standard deviation, total risk alpha, as well as the relationship between the coefficient of variation and jensen alpha , to decide if HEMOGENYX PHARMPLC performance from the past will be repeated in the future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days HEMOGENYX PHARMPLC LS 01 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
HEMOGENYX |
HEMOGENYX PHARMPLC Relative Risk vs. Return Landscape
If you would invest 495.00 in HEMOGENYX PHARMPLC LS 01 on December 13, 2024 and sell it today you would lose (97.00) from holding HEMOGENYX PHARMPLC LS 01 or give up 19.6% of portfolio value over 90 days. HEMOGENYX PHARMPLC LS 01 is currently producing negative expected returns and takes up 4.0708% volatility of returns over 90 trading days. Put another way, 36% of traded stocks are less volatile than HEMOGENYX, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
HEMOGENYX PHARMPLC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for HEMOGENYX PHARMPLC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as HEMOGENYX PHARMPLC LS 01, and traders can use it to determine the average amount a HEMOGENYX PHARMPLC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1102
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 5HU |
Estimated Market Risk
| 4.07 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.45 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average HEMOGENYX PHARMPLC is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HEMOGENYX PHARMPLC by adding HEMOGENYX PHARMPLC to a well-diversified portfolio.
HEMOGENYX PHARMPLC Fundamentals Growth
HEMOGENYX Stock prices reflect investors' perceptions of the future prospects and financial health of HEMOGENYX PHARMPLC, and HEMOGENYX PHARMPLC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HEMOGENYX Stock performance.
| Return On Equity | -0.32 | |||
| Return On Asset | -0.18 | |||
| Shares Outstanding | 979.75 M | |||
| EBITDA | (2.62 M) | |||
| Cash And Equivalents | 1.81 M | |||
| Total Debt | 1.63 M | |||
| Debt To Equity | 1.86 % | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (1.8 M) | |||
| Earnings Per Share | (0.01) X | |||
About HEMOGENYX PHARMPLC Performance
By analyzing HEMOGENYX PHARMPLC's fundamental ratios, stakeholders can gain valuable insights into HEMOGENYX PHARMPLC's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if HEMOGENYX PHARMPLC has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if HEMOGENYX PHARMPLC has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company was incorporated in 2013 and is headquartered in London, the United Kingdom. HEMOGENYX PHARM is traded on Frankfurt Stock Exchange in Germany.Things to note about HEMOGENYX PHARMPLC performance evaluation
Checking the ongoing alerts about HEMOGENYX PHARMPLC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for HEMOGENYX PHARMPLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| HEMOGENYX PHARMPLC is not yet fully synchronised with the market data | |
| HEMOGENYX PHARMPLC generated a negative expected return over the last 90 days | |
| HEMOGENYX PHARMPLC has high historical volatility and very poor performance | |
| Net Loss for the year was (2.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| HEMOGENYX PHARMPLC LS 01 has accumulated about 1.81 M in cash with (1.8 M) of positive cash flow from operations. | |
| Roughly 15.0% of the company shares are owned by insiders or employees |
- Analyzing HEMOGENYX PHARMPLC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HEMOGENYX PHARMPLC's stock is overvalued or undervalued compared to its peers.
- Examining HEMOGENYX PHARMPLC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating HEMOGENYX PHARMPLC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HEMOGENYX PHARMPLC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of HEMOGENYX PHARMPLC's stock. These opinions can provide insight into HEMOGENYX PHARMPLC's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for HEMOGENYX Stock analysis
When running HEMOGENYX PHARMPLC's price analysis, check to measure HEMOGENYX PHARMPLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HEMOGENYX PHARMPLC is operating at the current time. Most of HEMOGENYX PHARMPLC's value examination focuses on studying past and present price action to predict the probability of HEMOGENYX PHARMPLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HEMOGENYX PHARMPLC's price. Additionally, you may evaluate how the addition of HEMOGENYX PHARMPLC to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |